Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .We are coming up on being two months into 2026. Equities have become significantly more volatile here in February after posting modest gains in January to open the new year. While it is early in 2026, some changesBret Jensen has over 13 ...

I’m initiating coverage on Pure Storage, Inc. ( PSTG ) at a time when it looks like the company is sitting at an interesting intersection. On the one hand, it is a structural winner in enterpriseI’m Emmanuel Onwusah—a financial analyst, writer, and recovering engineer. I hold FMVA® and BIDA® certifications from the Corporate Finance Institute, and I spend most of my time creating pitch decks, building models, analyzing companies, and trying to make sense of where value meets narrative. My background is in p ...

Group 1 - The CAGNY organization is an all-volunteer entity that has significantly contributed to the growth of the conference over the years [1] - Recognition was given to past presidents of the organization for their contributions [2] - Current president Steve Strycula was acknowledged for his exceptional efforts in making this year's conference one of the best [2]

Core Viewpoint - The focus is on generating a 7%+ income yield through investments in energy stocks while minimizing principal loss risk [1]. Group 1: Investment Strategy - The investment strategy involves a portfolio of energy stocks, including both traditional and renewable energy sectors, targeting international companies with competitive advantages and strong dividend yields [1]. - The leader of the investing group, Energy Profits in Dividends, emphasizes income generation through energy stocks and closed-end funds (CEFs), while also managing risk through options [1]. Group 2: Research and Insights - Subscribers gain access to exclusive investment ideas and in-depth research that is not available to the general public, enhancing their investment decision-making [1]. - The service has been operational since 2010, providing both micro and macro-analysis of domestic and international energy companies [1].

Core Viewpoint - The individual investor adopts a contrarian investment style, focusing on stocks that have recently experienced sell-offs due to non-recurrent events, particularly when insiders are buying shares at lower prices [1] Investment Strategy - The investment portfolio is split approximately 50%-50% between shares and call options, indicating a balanced approach to risk and potential returns [1] - The investor's timeframe for holding positions typically ranges from 3 to 24 months, suggesting a medium-term investment horizon [1] - Fundamental analysis is employed to assess the health of companies, including their leverage and financial ratios compared to sector and industry averages [1] - Technical analysis is utilized to optimize entry and exit points, with a focus on support and resistance levels on weekly charts [1] Stock Selection Criteria - The investor screens for stocks that have undergone recent sell-offs, particularly those influenced by non-recurrent events, to identify potential buying opportunities [1] - Insider buying at lower prices serves as a key indicator for selecting stocks, reflecting confidence from company executives [1] - Professional background checks are conducted on insiders who purchase shares post-sell-off to ensure credibility and assess motivations [1]

Group 1 - The article promotes a weekly newsletter focused on stocks in the biotech, pharma, and healthcare industries, highlighting key trends and catalysts that influence market valuations [1] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group, which caters to both novice and experienced investors [1] - The investing group provides insights such as buy and sell ratings, product sales forecasts for major pharmaceutical companies, integrated financial statements, discounted cash flow analysis, and market-specific analyses [1]

PresentationBrandon OglenskiBarclays Bank PLC, Research Division Good afternoon, everyone. We're going to get this keynote lunch started here. So appreciate everyone coming down to Barclays 43rd Annual Industrial Select Conference. This is our third day. So thank you for making it through. It's been a very eventful conference again. I'm Brandon Oglenski, airline and transport analyst. But I just wanted to very quickly thank our corporate access and event marketing teams. There's a lot of folks that work aro ...

Charles Rotblut, CFA is the editor of the AAII Journal, the flagship publication of The American Association of Individual Investors (AAII). Charles provides both insight about individual investor sentiment and market analysis. He is also the author of "Better Good than Lucky: How Savvy Investors Create Fortune with the Risk-Reward Ratio" (W&A Publishing/Trader's Press).Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Microsoft Corporation ( MSFT ) reported Q2 earnings that beat analyst estimates on the top and bottom lines. The stock price, however, tanked, driven by concerns on AI capital expenditures and slowing growth for Azure. In this report, I discussDhie ...

Hanizam/iStock via Getty Images The following segment was excerpted from the First Eagle Small Cap Opportunity Fund Q4 2025 Commentary. Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025. Healthcare, materials and information technology were ...